Table 2.

Logistic regression model for completion of BREAST-Q Sexual Well-being at 1-year (n=2,941)

Patient Demographics	OR1	95% CI1	p-value
Age at Surgery	1.00	0.99, 1.01	0.9
Race  White  Asian  Black  Other	— 0.78 0.80 0.98	— 0.59, 1.02 0.60, 1.06 0.72, 1.33	0.070 0.12 0.9
Ethnicity  Not Hispanic  Hispanic  Unknown	— 0.80 0.98	— 0.60, 1.05 0.71, 1.33	0.11 0.9
Marital Status  Married  Separated  Single	— 0.69 1.00	— 0.53, 0.90 0.82, 1.22	0.006 >0.9
Language  English  Non-English	— 0.60	— 0.37, 0.96	0.034
Income	1.00	1.00, 1.00	0.7
Insurance  Commercial  Medicaid  Medicare  Self-Pay	— 0.67 0.95 0.56	— 0.48, 0.94 0.72, 1.25 0.24, 1.22	0.021 0.7 0.15
Body Mass Index (BMI)	1.0	0.98, 1.01	0.5
Smoking Status  Never Smoker  Current Smoker  Former Smoker	— 0.72 1.06	— 0.44, 1.17 0.88, 1.28	0.2 0.5
Menopause Status  Premenopausal  Postmenopausal  Unknown	— 1.66 2.08	— 1.23, 2.24 1.61, 2.69	<0.001 <0.001
Comorbidities  Diabetes  Cardiovascular Disease  Hypertension  Psychiatric Diagnoses  Lymphedema	1.06 1.02 0.88 1.05 1.29	0.76, 1.50 0.82, 1.27 0.72, 1.07 0.90, 1.24 0.82, 1.81	0.7 0.9 0.2 0.5 0.14
Clinical Characteristics
Lymph Node  Axillary lymph node dissection  Sentinel lymph node biopsy	1.04 1.28	0.65, 1.68 0.81, 2.04	0.9 0.3
Chemotherapy  None  Neoadjuvant  Adjuvant	— 0.87 1.07	— 0.69, 1.11 0.86, 1.33	0.3 0.6
Radiation  None  Neoadjuvant  Adjuvant	— 1.08 0.93	— 0.81, 1.46 0.73, 1.19	0.6 0.6
Aromatase inhibitor	0.95	0.80, 1.14	0.6
Mastectomy Type  Skin sparing  Nipple sparing	— 0.92	— 0.72, 1.17	0.5
Timing of Reconstruction  Immediate  Delayed	— 0.70	— 0.52, 0.95	0.022
Laterality  Bilateral  Unilateral	— 0.80	— 0.67, 0.94	0.008
Reconstruction Method  Implant  Autologous	— 2.93	— 2.32, 3.71	<0.001
Complications
Readmission within 90 days	0.85	0.63, 1.14	0.3
Reoperation within 90 days	1.12	0.90, 1.39	0.3

¹OR=Odds Ratio, CI= Confidence Interval